Showing results (321-330 of 902) with videos related to
Sort By:
Pageof 91
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 26, 2001
Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis CKlaus H W Boeker, Christian I Haberkorn, Dirk Michels, et al.Hepatology (Baltimore, Md.)|September 16, 2004
C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liverTom Luedde, Moritz Duderstadt, Konrad L Streetz, et al.United European Gastroenterology Journal|June 12, 2014
Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results databaseTobias Eggert, Katherine A McGlynn, Austin Duffy, et al.Biomedicines|June 28, 2023
Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV InfectionYanqin Du, Tanvi Khera, Zhaoli Liu, et al.Plos One|July 30, 2014
Anti-HDV IgM as a marker of disease activity in hepatitis deltaAnika Wranke, Benjamin Heidrich, Stefanie Ernst, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2017
Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)Anika Wranke, Lourdes M Pinheiro Borzacov, Raymundo Parana, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 23, 2025
Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus InfectionLisa Sandmann, Valerie Ohlendorf, Alena Ehrenbauer, et al.Alimentary Pharmacology & Therapeutics|June 3, 2022
Home-based, tunnelled peritoneal drainage system as an alternative treatment option for patients with refractory ascitesTammo L Tergast, Marie Griemsmann, Lena Stockhoff, et al.Frontiers in Public Health|April 1, 2022
Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019Anna Maisa, Christian Kollan, Matthias An der Heiden, et al.The Journal of Infectious Diseases|October 28, 2015
Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus InfectionFranziska Wandrer, Christine S Falk, Katharina John, et al.Pageof 91